Ventas Stock - Raymond James reinstates with Outperform rating
17.06.2026 - 18:48:47 | ad-hoc-news.de
Edited by ad hoc news Operations & Strategy Desk. Verified prior to publication on 06/17/2026, 18:47 CET. Details in the imprint.
Ventas Inc. (US92276F1003) returned to Raymond James' coverage list this week with an Outperform rating and a $94 price target, according to an analyst note dated 06/17/2026. The healthcare REIT remains a key play on senior housing demand and post-pandemic occupancy recovery.
All news and analysis on Ventas stock
Stay on top of Ventas with the latest market coverage, analyst views and company disclosures around its healthcare real estate portfolio.
Raymond James returns to the name
On 06/17/2026, Raymond James analyst David Rodgers reinstated coverage of Ventas with an Outperform rating and a $94 price target, highlighting improving senior housing fundamentals and the REIT's diversified portfolio. The note points to rising occupancy and better margins in key properties.
The Raymond James target stands well above the current Wall Street average of about $79.46, based on recent consensus data summarized by Stock Analysis. Consensus on the stock remains broadly positive, with an overall Buy recommendation from covering analysts.
Operations and earnings backdrop
Ventas positions itself as a leading owner and operator of senior housing and healthcare properties, giving it direct leverage to demographic tailwinds and healthcare spending. The portfolio includes independent living, assisted living, memory care and medical office assets across North America.
Recent commentary from analysts emphasizes that occupancy in senior housing has been recovering from pandemic lows, helping to rebuild net operating income and cash flows. Against this backdrop, the REIT's valuation metrics, including a relatively high P/E multiple versus peers, remain a talking point for investors.
How Ventas makes its money
Ventas generates revenue primarily from rent and related income on its portfolio of senior housing, medical office buildings and life science properties. Many properties operate under triple-net or management contracts, giving the REIT exposure to operating trends while keeping capital allocation in focus.
Where the stock trades today
Ventas shares (US92276F1003) trade on the New York Stock Exchange at around $77.70 as of 06/17/2026, 16:30 ET, based on recent market data.
Key facts on Ventas stock
- Company: Ventas Inc.
- ISIN: US92276F1003
- WKN: 893484
- Ticker: VTR
- Venue: NYSE
- Price (as of 06/17/2026, 16:30 ET): 77.70 USD
- Market cap: 36.78 billion USD (as of 06/17/2026)
- Sector / Industry: Real Estate - Healthcare REIT
- Index membership: S&P 500
- Next earnings date: 08/05/2026 (after market close)
This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.
